65,437 trials
Healthy
Primary: Cmax (Maximum Observed Concentration) — 2081.37; 2045.43 ng/mL
Healthy
Primary: Cmax (Maximum Observed Concentration) — 1477.573; 1484.677 ng/mL
Healthy
Primary: Cmax - Maximum Observed Concentration — 24.33; 23.62 ng/mL
Healthy
Primary: Cmax - Maximum Observed Concentration — 2936.10; 2955.65 ng/mL
Metastatic Breast Cancer
Primary: Tumor Response — 0; 0; 3; 25 participants — p=0.169
Cystic Fibrosis
Primary: Coefficient of Fat Absorption (%) — 88.62; 49.78 Percentage — p=<0.001
Familial Hypercholesterolemia
Primary: Percent Change in Low-density Lipoprotein Cholesterol (LDL-C) From Baseline (Day 0) to the End of the 12-week Double-blind Treatment Phase — -38.5; -44.4; -50.2; -0.5…
Hemophilia A
Primary: Number of Patients Who Achieved Hemostatic Efficacy After Surgery — 15; 3; 5; 2 patients
Benign Prostatic Hyperplasia
Primary: Change From Baseline to 12 Week Endpoint in International Prostate Symptom Score (IPSS) Total Score — 17.3; 17.1; 17.7; -4.2 units on a scale — p=0.073
Computed Tomography · Diagnostic Imaging
Primary: The Quality of Visualization of the Contrast-Enhanced Computed Tomography (CECT) Images, Based on the Blinded Readers' Assessment. — 366; 17; 16; 3 Number of…
Asthma
Primary: Effective Dose 50% (ED50) — 141 ug
Major Depressive Disorder
Primary: Change From Baseline to 8 Weeks in 24-Item Hamilton Depression Rating Scale (HAMD-24) Item 7 (Work and Activities) — -1.32; -1.07; -1.37; -0.93 units on a scale — p=0.051
Pharmacokinetics
Primary: Maximum Plasma Concentration(Cmax) — 9.58; 6.63; 9.81; 7.47 ug/mL
Gingivitis
Primary: Level of Gingival Crevicular Fluid Interleukin - 1 (GCF IL-1) at 2 Hours — 492.2; 326.3 Micrograms — p=0.05
Eating Disorders
Primary: Weight Gain — 6.2; 1.5 lbs